4-(Bromomethyl)-3-nitrobenzoic acid
CAS: 55715-03-2
Ref. 3D-FB12523
| 2g | Descontinuado | ||
| 5g | Descontinuado | ||
| 10g | Descontinuado | ||
| 25g | Descontinuado | ||
| 50g | Descontinuado |
Informação sobre produto
Nome:
4-(Bromomethyl)-3-nitrobenzoic acid
Sinónimos:
- 4-(Bromomethyl)-3-Nitrobenzoate
Descrição:
4-(Bromomethyl)-3-nitrobenzoic acid (4BMB) is a specific antibody that can be used for the treatment of cancer. 4BMB binds to the antigen CD19, which is expressed on the surface of B cells and some plasma cells. It has been shown to inhibit cell proliferation in vitro and in vivo. This drug has also been shown to have cytotoxic effects against tumor cells by inducing apoptosis. 4BMB is synthesized using a solid-phase synthesis method, and it has shown efficient binding affinity with CD19 antigen, as well as high specificity. The antibody can be successfully produced in large quantities, making it an ideal candidate for regenerative medicine.
Aviso:
Os nossos productos estão destinados exclusivamente para uso em laboratório. Para qualquer outra aplicação, por favor entre em contacto.
Marca:
Biosynth
Armazenamento a longo prazo:
Notas:
Propriedades químicas
Peso molecular:
260.04 g/mol
Fórmula:
C8H6BrNO4
Pureza:
Min. 95%
MDL:
Ponto de fusão:
Ponto de ebulição:
Ponto de inflamação:
Densidade:
Concentração:
EINECS:
Merck:
Código HS:
